New hope for kids with heartburn: study tests daily pill

NCT ID NCT02616302

Completed Symptom relief Sponsor: Takeda Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times

Summary

This study tests whether a daily medicine called dexlansoprazole can safely reduce symptoms of gastroesophageal reflux disease (GERD) in children aged 2 to 11 years who have heartburn but no damage to their esophagus. About 71 children will take the medicine or a placebo for 12 weeks, and parents or children will report symptoms daily using a diary. The goal is to see if the medicine increases the number of days without pain or burning.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROESOPHAGEAL REFLUX DISEASE (GERD)

Contacts and locations

Locations

Boca Clinical Trials Mexico S.C.

Querétaro, Putumayo, 1120, Mexico
Centro Medico Imbanaco de Cali S.A

Cali, 760042, Colombia
Childrens Center for Digestive Health Care, LLC

Mobile, Alabama, 36604, United States
Childrens Hospital of The Kings Daughters

Jackson, Mississippi, 39232, United States
Clinical Research Institute S.C.

Tlalnepantla, State of Mexico, 54055, Mexico
El Cielo Medical Center

Puebla City, 72160, Mexico
Fundacion Valle del Lili

Cali, 760032, Colombia
GI For Kids

Atlanta, Georgia, 30342, United States
Gabinet Lekarski Bartosz Korczowski

Rzeszów, PL, 35-302, Poland
Hospital Universitario San Ignacio

Bogotá, 110231, Colombia
In Vivo Osrodek Badan Klinicznych

Bydgoszcz, 85-048, Poland
Instytut "Pomnik - Centrum Zdrowia Dziecka", Oddzial Gastroenterologii, Hepatologii, Zaburzen odzywiania i Pediatrii

Warsaw, 04-730, Poland
London Health Sciences Centre Children's Hospital

London, Ontario, N6A 5W9, Canada
National Research Centers

Norfolk, Virginia, 23507, United States
SMIQ, S. DE R.L. DE C.V. Queretaro

Querétaro, 76070, Mexico
The University of Chicago

Cleveland, Ohio, 44106, United States
University of Utah/ Primary Childrens Hospital

San Francisco, California, 94158, United States
Women and Children's Health Research Institute

Edmonton, Alberta, T6G 1C9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.